COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs (Q36399564)

14 August 2017

1 reference

title

COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs (English)

1 reference

14 August 2017

0 references

1 reference

Timothy D Warner

2

0 references

author name string

Jane A Mitchell

series ordinal

1

1 reference

14 August 2017

1 January 2006

1 reference

Nature Reviews Drug Discovery

14 August 2017

1 reference

14 August 2017

5

1 reference

14 August 2017

1

1 reference

14 August 2017

75-86

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd1929

14 August 2017

0 references

cites work

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

Indomethacin and aspirin abolish prostaglandin release from the spleen

31 March 2020

1 reference

Aspirin selectively inhibits prostaglandin production in human platelets

31 March 2020

1 reference

31 March 2020

Cyclooxygenases 1 and 2

1 reference

Cyclooxygenases: structural, cellular, and molecular biology

31 March 2020

1 reference

The coxibs, selective inhibitors of cyclooxygenase-2.

31 March 2020

1 reference

The development of COX2 inhibitors

31 March 2020

1 reference

Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

31 March 2020

1 reference

Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation

31 March 2020

1 reference

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

31 March 2020

1 reference

Human cyclooxygenase-2 cDNA

31 March 2020

1 reference

Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme

31 March 2020

1 reference

cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase

31 March 2020

1 reference

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

31 March 2020

1 reference

Cyclooxygenase-2 as a therapeutic target

31 March 2020

1 reference

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

31 March 2020

1 reference

Coxibs and cardiovascular disease

31 March 2020

1 reference

Vioxx, the implosion of Merck, and aftershocks at the FDA.

31 March 2020

1 reference

Failing the public health--rofecoxib, Merck, and the FDA.

31 March 2020

1 reference

Raising the safety bar--the FDA's coxib meeting

31 March 2020

1 reference

Cyclooxygenase inhibition and cardiovascular risk

31 March 2020

1 reference

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

31 March 2020

1 reference

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

31 March 2020

1 reference

Diverse functional coupling of cyclooxygenase 1 and 2 with final prostanoid synthases in liver macrophages

31 March 2020

1 reference

Cloning and characterization of cyclooxygenase-1b (putative cyclooxygenase-3) in rat.

31 March 2020

1 reference

Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?

31 March 2020

1 reference

Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues

31 March 2020

1 reference

Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties

31 March 2020

1 reference

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

31 March 2020

1 reference

Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy

31 March 2020

1 reference

Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors

31 March 2020

1 reference

Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa.

31 March 2020

1 reference

NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2

31 March 2020

1 reference

Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events

31 March 2020

1 reference

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

31 March 2020

1 reference

COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice

31 March 2020

1 reference

Nomenclature for COX-2 inhibitors.

31 March 2020

1 reference

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

31 March 2020

1 reference

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

31 March 2020

1 reference

Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase

31 March 2020

1 reference

Aspirin: new cardiovascular uses for an old drug

31 March 2020

1 reference

31 March 2020

1 reference

Altered pain perception and inflammatory response in mice lacking prostacyclin receptor

31 March 2020

1 reference

Role of prostacyclin in the cardiovascular response to thromboxane A2

31 March 2020

1 reference

Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets

31 March 2020

1 reference

Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis

31 March 2020

1 reference

Flow cytometry analysis of platelet cyclooxygenase-2 expression: induction of platelet cyclooxygenase-2 in patients undergoing coronary artery bypass grafting

31 March 2020

1 reference

Cyclooxygenase COX-2a, a novel COX-2 mRNA variant, in platelets from patients after coronary artery bypass grafting

31 March 2020

1 reference

Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease

31 March 2020

1 reference

Narrative review: aspirin resistance and its clinical implications

31 March 2020

1 reference

Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis

31 March 2020

1 reference

Induction of cyclooxygenase-2 in human saphenous vein and internal mammary artery

31 March 2020

1 reference

Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: role of endogenous prostanoids

31 March 2020

1 reference

Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle

31 March 2020

1 reference

Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear str

31 March 2020

1 reference

Transcriptional and posttranscriptional regulation of cyclooxygenase-2 expression by fluid shear stress in vascular endothelial cells

31 March 2020

1 reference

Effects of shear stress on eicosanoid gene expression and metabolite production in vascular endothelium as studied in a novel biomechanical perfusion model

31 March 2020

1 reference

Shear stress differentially regulates PGHS-1 and PGHS-2 protein levels in human endothelial cells

31 March 2020

1 reference

Asynchronous shear stress and circumferential strain reduces endothelial NO synthase and cyclooxygenase-2 but induces endothelin-1 gene expression in endothelial cells.

31 March 2020

1 reference

Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells

31 March 2020

1 reference

Gene expression profile of human endothelial cells exposed to sustained fluid shear stress

31 March 2020

1 reference

DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells

31 March 2020

1 reference

Effect on endothelial cell gene expression of shear stress, oxygen concentration, and low-density lipoprotein as studied by a novel flow cell culture system

31 March 2020

1 reference

Biomechanical activation of vascular endothelium as a determinant of its functional phenotype.

31 March 2020

1 reference

Global analysis of shear stress-responsive genes in vascular endothelial cells.

31 March 2020

1 reference

Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature.

31 March 2020

1 reference

Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow

31 March 2020

1 reference

Large scale isolation of non-uniform shear stress-responsive genes from cultured human endothelial cells through the preparation of a subtracted cDNA library

31 March 2020

1 reference

Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2)

31 March 2020

1 reference

Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages

31 March 2020

1 reference

Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions

31 March 2020

1 reference

Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries

31 March 2020

1 reference

Synergy between cyclo-oxygenase-2 induction and arachidonic acid supply in vivo: consequences for nonsteroidal antiinflammatory drug efficacy

31 March 2020

1 reference

Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

31 March 2020

1 reference

Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function

31 March 2020

1 reference

Effects of COX-2 inhibitors on aortic prostacyclin production in cholesterol-fed rabbits

31 March 2020

1 reference

COX-2-derived prostacyclin modulates vascular remodeling.

31 March 2020

1 reference

Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.

31 March 2020

1 reference

Inhibition of prostaglandin H2 synthases by salicylate is dependent on the oxidative state of the enzymes.

31 March 2020

1 reference

Cellular mechanisms of acetaminophen: role of cyclo-oxygenase.

31 March 2020

1 reference

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

31 March 2020

1 reference

Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition

31 March 2020

1 reference

Cycloxygenase-2 is expressed in vasculature of normal and ischemic adult human kidney and is colocalized with vascular prostaglandin E2 EP4 receptors

31 March 2020

1 reference

Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans.

31 March 2020

1 reference

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

31 March 2020

1 reference

Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor

31 March 2020

1 reference

Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension

31 March 2020

1 reference

Effects of celecoxib and naproxen on renal function in the elderly

31 March 2020

1 reference

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

31 March 2020

1 reference

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

31 March 2020

1 reference

Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis

31 March 2020

1 reference

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

31 March 2020

1 reference

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

31 March 2020

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

31 March 2020

1 reference

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

31 March 2020

1 reference

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

31 March 2020

1 reference

A coxib a day won't keep the doctor away

31 March 2020

1 reference

Are Cyclooxygenase-2 Inhibitors Being Taken Only by Those Who Need Them?

31 March 2020

1 reference

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

31 March 2020

1 reference

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

31 March 2020

1 reference

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

31 March 2020

1 reference

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

31 March 2020

1 reference

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

31 March 2020

1 reference

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

31 March 2020

1 reference

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

31 March 2020

1 reference

Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects

31 March 2020

1 reference

Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population.

31 March 2020

1 reference

Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study

31 March 2020

1 reference

Tailoring arthritis therapy in the wake of the NSAID crisis

31 March 2020

1 reference

Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction

31 March 2020

1 reference

The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD1929

1 reference

PubMed ID

16485347

Dimensions Publication ID

14 August 2017

0 references

1 reference

PubMed ID

16485347